Dexco Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Dexco wird ein jährliches Gewinn- und Umsatzwachstum von 16.4% bzw. 4.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 4.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.2% betragen.

Wichtige Informationen

16.4%

Wachstumsrate der Gewinne

4.9%

EPS-Wachstumsrate

Forestry Gewinnwachstum	22.6%
Wachstumsrate der Einnahmen	4.7%
Zukünftige Eigenkapitalrendite	11.2%
Analystenabdeckung	Good
Zuletzt aktualisiert	16 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

May 13

Recent updates

There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital

May 11

Is Dexco (BVMF:DXCO3) Using Too Much Debt?

Apr 27

Here's Why I Think Dexco (BVMF:DXCO3) Is An Interesting Stock

Mar 15

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Feb 24

The Return Trends At Dexco (BVMF:DXCO3) Look Promising

Feb 04

Here's Why We Think Dexco (BVMF:DXCO3) Is Well Worth Watching

Dec 08

These 4 Measures Indicate That Dexco (BVMF:DXCO3) Is Using Debt Safely

Nov 20

Dexco (BVMF:DXCO3) Is Doing The Right Things To Multiply Its Share Price

Oct 25

Does Dexco (BVMF:DXCO3) Deserve A Spot On Your Watchlist?

Sep 02

Duratex (BVMF:DTEX3) Has A Rock Solid Balance Sheet

Aug 18

Is It Too Late To Consider Buying Duratex S.A. (BVMF:DTEX3)?

Aug 05

Duratex (BVMF:DTEX3) Shareholders Will Want The ROCE Trajectory To Continue

Jul 21

Does Duratex (BVMF:DTEX3) Deserve A Spot On Your Watchlist?

May 28

Is Duratex (BVMF:DTEX3) Using Too Much Debt?

May 15

Why Duratex S.A. (BVMF:DTEX3) Could Be Worth Watching

Apr 30

Duratex S.A.'s (BVMF:DTEX3) 1.5% Dividend Yield Looks Pretty Interesting

Apr 17

The Return Trends At Duratex (BVMF:DTEX3) Look Promising

Mar 22

Duratex S.A. (BVMF:DTEX3) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Mar 08

Here's Why I Think Duratex (BVMF:DTEX3) Is An Interesting Stock

Feb 23

Gewinn- und Umsatzwachstumsprognosen

BOVESPA:DXCO3 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	8,713	738	769	1,061	5
12/31/2025	8,214	610	941	1,136	8
12/31/2024	7,728	336	53	646	8
3/31/2024	7,607	602	39	1,352	N/A
12/31/2023	7,383	790	98	1,346	N/A
9/30/2023	7,415	812	-153	975	N/A
6/30/2023	7,808	668	-151	993	N/A
3/31/2023	8,068	680	-456	726	N/A
12/31/2022	8,487	756	-419	794	N/A
9/30/2022	8,757	1,128	15	1,226	N/A
6/30/2022	8,773	1,229	142	1,227	N/A
3/31/2022	8,533	1,776	550	1,505	N/A
12/31/2021	8,170	1,725	851	1,708	N/A
9/30/2021	7,813	1,446	863	1,585	N/A
6/30/2021	7,414	1,315	1,326	1,930	N/A
3/31/2021	6,486	574	1,289	1,813	N/A
12/31/2020	5,880	454	1,020	1,508	N/A
9/30/2020	5,472	437	1,089	1,536	N/A
6/30/2020	5,003	341	740	1,187	N/A
3/31/2020	5,101	434	578	1,050	N/A
12/31/2019	5,012	406	653	1,108	N/A
9/30/2019	4,789	-21	273	744	N/A
6/30/2019	4,993	327	-22	445	N/A
3/31/2019	5,016	425	-4	437	N/A
12/31/2018	4,949	432	-59	383	N/A
9/30/2018	4,789	658	-85	303	N/A
6/30/2018	4,296	365	-9	356	N/A
3/31/2018	4,045	223	-9	340	N/A
12/31/2017	3,991	185	N/A	405	N/A
9/30/2017	3,917	125	N/A	470	N/A
6/30/2017	3,864	72	N/A	346	N/A
3/31/2017	3,960	47	N/A	540	N/A
12/31/2016	3,910	24	N/A	451	N/A
9/30/2016	3,836	50	N/A	400	N/A
6/30/2016	3,911	48	N/A	493	N/A
3/31/2016	3,863	85	N/A	443	N/A
12/31/2015	3,963	183	N/A	574	N/A
9/30/2015	4,048	221	N/A	691	N/A
6/30/2015	4,064	275	N/A	837	N/A
3/31/2015	4,056	296	N/A	739	N/A
12/31/2014	3,985	390	N/A	678	N/A
9/30/2014	3,953	366	N/A	685	N/A
6/30/2014	3,923	450	N/A	626	N/A
3/31/2014	3,937	526	N/A	709	N/A
12/31/2013	3,873	534	N/A	768	N/A
9/30/2013	3,795	621	N/A	713	N/A
6/30/2013	3,672	582	N/A	732	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: DXCO3Das prognostizierte Gewinnwachstum (16.4% pro Jahr) liegt über der Sparquote (9.9%).

Ertrag vs. Markt: DXCO3Die Erträge des Unternehmens (16.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt BR (14% pro Jahr).

Hohe Wachstumserträge: DXCO3Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: DXCO3Die Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt BR (6.8% pro Jahr).

Hohe Wachstumseinnahmen: DXCO3Die Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: DXCO3Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.2 %).

Dexco Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

Consensus EPS estimates fall by 26%

Recent updates

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Consensus EPS estimates increase by 13%

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 26%

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Consensus EPS estimates fall by 37%, revenue upgraded

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Consensus EPS estimates increase by 19%, revenue downgraded

New minor risk - Earnings quality

New minor risk - Share price stability

Full year 2023 earnings: EPS exceeds analyst expectations

Now 25% overvalued after recent price rise

Dexco S.A. to Report Q4, 2023 Results on Mar 06, 2024

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

Dexco S.A., Annual General Meeting, Apr 26, 2024

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Consensus EPS estimates increase by 12%, revenue downgraded

Consensus EPS estimates increase by 45%, revenue downgraded

Price target decreased by 8.5% to R$9.82

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

Is Dexco (BVMF:DXCO3) A Risky Investment?

Second quarter 2023 earnings released

Consensus EPS estimates increase by 19%

Consensus EPS estimates increase by 22%

Returns At Dexco (BVMF:DXCO3) Are On The Way Up

Consensus EPS estimates increase by 10%

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 13%

Investor sentiment improves as stock rises 24%

First quarter 2023 earnings released: EPS: R$0.18 (vs R$0.27 in 1Q 2022)

Consensus EPS estimates increase by 12%, revenue downgraded

Consensus EPS estimates increase by 15%

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 24%

Price target decreased by 10% to R$10.91

We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)

Price target decreased by 10.0% to R$12.65

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger

Price target decreased to R$15.76

Less than half of directors are independent

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues miss analyst expectations

Consensus EPS estimates increase by 28%

Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?

Investors Will Want Dexco's (BVMF:DXCO3) Growth In ROCE To Persist

We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 10%

Second quarter 2022 earnings released

Is There Now An Opportunity In Dexco S.A. (BVMF:DXCO3)?

First quarter 2022 earnings: Revenues exceed analyst expectations

There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital

Consensus forecasts updated

Is Dexco (BVMF:DXCO3) Using Too Much Debt?

Less than half of directors are independent

Here's Why I Think Dexco (BVMF:DXCO3) Is An Interesting Stock

Consensus forecasts updated

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Consensus forecasts updated

Full year 2021 earnings: Revenues exceed analyst expectations

The Return Trends At Dexco (BVMF:DXCO3) Look Promising

Here's Why We Think Dexco (BVMF:DXCO3) Is Well Worth Watching

These 4 Measures Indicate That Dexco (BVMF:DXCO3) Is Using Debt Safely